Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

CARsgen and Roche Partner on Clinical Study for Gastric Cancer Treatment

January 21, 2025
Company

Zennova Pharmaceuticals Completes Phase 1 of Chengdu Manufacturing and R&D Center

January 21, 2025
CompanyDeals

Tigermed Completes Acquisition of Croatia-Based CRO Marti Farm

January 21, 2025
Policy / Regulatory

China Unveils Measures to Boost Foreign Investment in R&D Centers

January 21, 2025
CompanyDrug

Haisco’s Prostate Cancer Drug HSK38008 and DPP-4 Inhibitor HSK7653 Accepted for Review

January 21, 2025
CompanyDeals

RemeGen and Allist Partner to Assess ADC and EGFR Inhibitor Combination in NSCLC

January 21, 2025
CompanyDrug

HealZen Therapeutics Gains NMPA Approval for HZ-A-018 Clinical Study in Autoimmune Diseases

January 21, 2025
CompanyDrug

Betta Pharmaceuticals’ BPI-D0316 Accepted for Review by CDE for First-Line NSCLC

January 21, 2025
CompanyDrug

Jiangsu Alpha Biopharma’s Zorifertinib NDA Accepted for Review by CDE

January 21, 2025
CompanyDrug

Grand Pharma’s Jext Auto-Injector Approved for Import into Greater Bay Area

January 21, 2025
CompanyDrug

Abbisko’s ABSK021 Receives FDA Breakthrough Therapy Designation for TGCT

January 21, 2025
CompanyDrug

CDE Grants Priority Review Status to Kechow’s HL-085 for Melanoma Treatment

January 21, 2025
1 2 3 4 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up